Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (386)	12/9/1998 1:48:00 PM
From: Czechsinthemail	Read Replies (1) \| Respond to of 4474

Rick, The suicide gene system sounds interesting. What is your sense of how far along ARIAD may be compared with other companies researching similar approaches? Aren't a number of biotech companies researching killer gene approaches for treating cancer? The potential seems incredible. My concern, particularly with questions up around ARIAD's financing, is the path from here to there and whether someone else is likely to get there first. Baird